Showing results (121-130 of 2,810) with videos related to
Sort By:
Pageof 281
Expert Opinion on Drug Safety|August 16, 2023
Sublingual/Buccal buprenorphine and dental problems: a pharmacovigilance studyRomain Barus, François Montastruc, Claire de Canecaude, et al.Expert Opinion on Drug Safety|August 17, 2023
Weight gain, gender, and antipsychotics: a disproportionality analysis of the FDA Adverse Event Reporting System database (FAERS)Eleni Stamoula, Vasileios-Periklis Stamatellos, Theofanis Vavilis, et al.Expert Opinion on Drug Safety|August 14, 2023
A real-world disproportionality analysis of ospemifene: data mining of the public version of FDA adverse event reporting systemHaixiao Wen, Chong Lu, Meng Zhang, et al.Expert Opinion on Drug Safety|August 24, 2023
A pharmacovigilance study of the association between antipsychotic drugs and venous thromboembolism based on Food and Drug Administration Adverse Event Reporting System dataYu Yan, Ling Wang, Yanling Yuan, et al.Expert Opinion on Drug Safety|October 18, 2023
Comparative efficacy and safety of different doses of ponatinib versus other tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia: a systematic review and network meta-analysisShan Zhang, Hurong Lai, Huijun Chen, et al.Expert Opinion on Drug Safety|October 14, 2023
Data mining and analysis of the adverse events derived signals of 4 gadolinium-based contrast agents based on the US Food and drug administration adverse event reporting systemLu Wang, Yinglin Wang, Quan ZhaoExpert Opinion on Drug Safety|October 24, 2023
Real-world safety of icosapent ethyl: analysis based on spontaneous reports in FAERS databaseHaixia Cai, Beixi Jia, Zhonghua Fu, et al.Expert Opinion on Drug Safety|October 5, 2023
Characteristics of adverse drug reactions induced by flutamide and bicalutamide: a real-world pharmacovigilance study using FAERSYu Sun, Tao Xu, Suyan Zhu, et al.Expert Opinion on Drug Safety|July 7, 2023
Proton pump inhibitors use prior to COVID-19 hospitalization is associated with higher Clostridioides difficile infection rateMarko Lucijanic, Nikolina Busic, Josip Stojic, et al.Expert Opinion on Drug Safety|July 21, 2023
Drug-drug interaction of Nirmatrelvir/ritonavir and tacrolimus: A potential risk disproportionality analysis of nephrotoxicity from COVID-19 reports in FAERSFuhong Qin, Huiling Wang, Meng Li, et al.Pageof 281